RhumbLine Advisers’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-4,540
| Closed | -$15K | – | 2990 |
|
|
2017
Q1 | $15K | Buy |
4,540
+230
| +5% | +$760 | ﹤0.01% | 2841 |
|
|
2016
Q4 | $22K | Sell |
4,310
-2,777
| -39% | -$14.2K | ﹤0.01% | 2842 |
|
|
2016
Q3 | $179K | Buy |
7,087
+38
| +0.5% | +$960 | ﹤0.01% | 2713 |
|
|
2016
Q2 | $174K | Buy |
7,049
+2,267
| +47% | +$56K | ﹤0.01% | 2803 |
|
|
2016
Q1 | $138K | Buy |
4,782
+13
| +0.3% | +$375 | ﹤0.01% | 2838 |
|
|
2015
Q4 | $177K | Buy |
4,769
+457
| +11% | +$17K | ﹤0.01% | 2836 |
|
|
2015
Q3 | $210K | Buy |
4,312
+478
| +12% | +$23.3K | ﹤0.01% | 2764 |
|
|
2015
Q2 | $264K | Buy |
+3,834
| New | +$264K | ﹤0.01% | 2745 |
|